Financials Insmed Incorporated

Equities

INSM

US4576693075

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 02:30:00 06/03/2026 am IST			5-day change	1st Jan Change
143.57 ^USD	-4.21%		-4.29%	-17.51%

02/03	Insmed Incorporated Presents at TD Cowen 46th Annual Health Care Conference, Mar-02-2026 09:50 AM
24/02	Insmed Insider Sold Shares Worth $1,615,257, According to a Recent SEC Filing	MT

Projected Income Statement: Insmed Incorporated

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net sales ¹	188.5	245.4	305.2	363.7	606.4	1,680	2,719	3,847
Change	-	30.19%	24.39%	19.17%	66.73%	177.03%	61.87%	41.48%
EBITDA ¹	-359.8	-447	-699	-867.2	-1,230	-508.8	80.12	748.7
Change	-	-24.22%	-56.39%	-24.06%	-41.87%	58.64%	115.75%	834.48%
EBIT ¹	-375.1	-457.3	-709.6	-878.3	-1,247	-517.3	250.8	995.1
Change	-	-21.92%	-55.17%	-23.76%	-41.96%	58.51%	148.48%	296.74%
Interest Paid ¹	-40.47	-26.45	-81.69	-84.91	-83.8	-77.07	-73.88	-70.94
Earnings before Tax (EBT) ¹	-436.4	-480.2	-747	-910.1	-1,272	-569.2	210.3	977.9
Change	-	-10.02%	-55.58%	-21.83%	-39.74%	55.25%	136.96%	364.92%
Net income ¹	-434.7	-481.5	-749.6	-913.8	-1,277	-574.5	165.8	898.7
Change	-	-10.79%	-55.66%	-21.91%	-39.73%	55%	128.87%	441.91%
Announcement Date	17/02/22	23/02/23	22/02/24	20/02/25	19/02/26	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4
Net sales ¹	40.21	45.37	46.76	56.12	53.11	65.22	67.73	59.3	65.21	77.23	79.07	83.69	75.5	90.34	93.42	104.4	92.82	107.4	142.3	263.8	302.3	383.8	458	551.5	463.9	529.4	577.4	593.9
Change	-	12.81%	3.07%	20.03%	-5.38%	22.81%	3.85%	-12.45%	9.97%	18.42%	2.39%	5.84%	-9.79%	19.66%	3.41%	11.79%	-11.12%	15.72%	32.52%	85.36%	14.59%	26.95%	19.31%	20.43%	-15.88%	14.12%	9.06%	2.86%
EBITDA	-	-84.92	-100.1	-95.43	-87.28	-86.1	-125.6	-148	-145.6	-233	-144.9	-175.5	-	-286.2	-210.7	-227.7	-245	-309.1	-362	-314.2	-	-	-	-	-	-	-	-
Change	-	-	-17.9%	4.68%	8.53%	1.36%	-45.87%	-17.87%	1.61%	-59.94%	37.79%	-21.13%	-	-	26.38%	-8.05%	-7.61%	-26.18%	-17.11%	13.21%	-	-	-	-	-	-	-	-
EBIT ¹	-83.83	-88.57	-103.6	-99.08	-89.83	-88.32	-127.7	-151.5	-148.2	-235.5	-147.7	-178.3	-145.5	-288.9	-213.4	-230.4	-248.1	-312.9	-366	-319.7	-197.8	-149.4	-109.8	-62.09	-31.75	7.2	20.25	33.05
Change	-	-5.65%	-16.99%	4.38%	9.33%	1.69%	-44.59%	-18.62%	2.19%	-58.97%	37.3%	-20.72%	18.38%	-98.55%	26.12%	-7.96%	-7.69%	-26.09%	-16.98%	12.64%	38.15%	24.44%	26.53%	43.44%	48.87%	122.68%	181.25%	63.21%
Charge d'intérêts ¹	-7.559	-10.32	-11.24	-11.35	-3.291	-3.357	-3.353	-16.44	-20	-20.62	-20.29	-20.78	-21.04	-21.27	-21.05	-21.55	-	-21.24	-20.38	-20.6	-19.74	-19.91	-20.04	-20.15	-20.6	-20.6	-20.6	-20.6
Earnings before Tax (EBT) ¹	-91.4	-116.7	-115.3	-113	-94.24	-95.14	-130.8	-160	-159.3	-244.3	-158.4	-185.1	-156.5	-299.8	-219.5	-234.3	-255.7	-320.4	-368.7	-326.9	-210.7	-166.8	-126.2	-78.05	-40.8	-1.05	18	32.95
Change	-	-27.68%	1.21%	1.97%	16.62%	-0.96%	-37.45%	-22.35%	0.45%	-53.36%	35.16%	-16.84%	15.43%	-91.54%	26.77%	-6.73%	-9.13%	-25.33%	-15.06%	11.33%	35.55%	20.82%	24.36%	38.15%	47.73%	97.43%	1,814.29%	83.06%
Net income ¹	-91.64	-117.3	-112.7	-113	-94.62	-95.64	-131.1	-160.1	-159.8	-244.8	-158.9	-186.1	-157.1	-300.6	-220.5	-235.5	-256.6	-321.7	-370	-328.5	-212.1	-167.9	-127.5	-78.71	-40.8	-1.05	18	32.45
Change	-	-28.02%	3.93%	-0.23%	16.25%	-1.08%	-37.12%	-22.1%	0.22%	-53.23%	35.08%	-17.07%	15.57%	-91.36%	26.64%	-6.81%	-8.93%	-25.37%	-15.03%	11.23%	35.43%	20.82%	24.1%	38.26%	48.16%	97.43%	1,814.29%	80.28%
Announcement Date	06/05/21	05/08/21	28/10/21	17/02/22	05/05/22	04/08/22	27/10/22	23/02/23	04/05/23	03/08/23	26/10/23	22/02/24	09/05/24	08/08/24	31/10/24	20/02/25	08/05/25	07/08/25	30/10/25	19/02/26	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Insmed Incorporated

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net Debt ¹	-135	156	560	-142	-889	-715	-796	-1,622
Change	-	215.56%	258.97%	-125.36%	-526.06%	19.58%	-11.33%	-103.77%
Announcement Date	17/02/22	23/02/23	22/02/24	20/02/25	19/02/26	-	-	-

¹USD in Million

Estimates

Cash Flow Forecast: Insmed Incorporated

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
CAPEX ¹	7.289	9.878	13.29	21.92	32.56	40.14	67.32	94.09
Change	-	35.52%	34.52%	64.98%	48.52%	23.28%	67.7%	39.78%
Free Cash Flow (FCF) ¹	-370.6	-410.3	-549.5	-705.8	-967.6	-590	-32.55	791.4
Change	-	-10.72%	-33.93%	-28.44%	-37.09%	39.03%	94.48%	2,531.23%
Announcement Date	17/02/22	23/02/23	22/02/24	20/02/25	19/02/26	-	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: Insmed Incorporated

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	-190.93%	-182.18%	-229.04%	-238.44%	-202.88%	-30.29%	2.95%	19.46%
EBIT Margin (%)	-199.03%	-186.39%	-232.51%	-241.47%	-205.59%	-30.79%	9.22%	25.86%
EBT Margin (%)	-231.57%	-195.69%	-244.76%	-250.22%	-209.71%	-33.88%	7.74%	25.42%
Net margin (%)	-230.63%	-196.26%	-245.59%	-251.24%	-210.54%	-34.2%	6.1%	23.36%
FCF margin (%)	-196.64%	-167.23%	-180.05%	-194.06%	-159.55%	-35.12%	-1.2%	20.57%
FCF / Net Income (%)	85.26%	85.21%	73.31%	77.24%	75.78%	102.68%	-19.63%	88.05%
Profitability
ROA	-42.62%	-33.21%	-50.2%	-54.47%	-	-	-	-
ROE	-126.66%	-193.22%	-	-	-249.28%	-95.79%	-35.04%	37.77%
Financial Health
Leverage (Debt/EBITDA)	-	-0.35x	-0.8x	-	-	-	-	-
Debt / Free cash flow	-	-0.38x	-1.02x	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	3.87%	4.03%	4.35%	6.03%	5.37%	2.39%	2.48%	2.45%
CAPEX / EBITDA (%)	-2.03%	-2.21%	-1.9%	-2.53%	-2.65%	-7.89%	84.02%	12.57%
CAPEX / FCF (%)	-1.97%	-2.41%	-2.42%	-3.11%	-3.37%	-6.8%	-206.81%	11.89%
Items per share
Cash flow per share ¹	-3.241	-3.255	-3.819	-4.169	-4.698	-1.262	2.572	-
Change	-	-0.44%	-17.34%	-9.16%	-12.7%	73.14%	303.77%	-
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	3.994	0.6483	-2.364	1.74	3.713	1.54	2.677	6.384
Change	-	-83.77%	-464.58%	173.6%	113.44%	-58.52%	73.82%	138.46%
EPS ¹	-3.88	-3.91	-5.34	-5.57	-6.42	-2.695	0.7939	3.881
Change	-	-0.77%	-36.57%	-4.31%	-15.26%	58.02%	129.46%	388.87%
Nbr of stocks (in thousands)	1,18,372	1,35,477	1,43,062	1,78,903	2,13,273	2,15,552	2,15,552	2,15,552
Announcement Date	17/02/22	23/02/23	22/02/24	20/02/25	19/02/26	-	-	-